Collusion and Malfeasance: What's the Chance That All Four Companies Would Pick the Spike Protein?

JungleEaglesNest
Published on Jun 6, 2022
Collusion and Malfeasance: What's the Chance That All Four Companies Would Pick the Spike Protein?
Suboptimal Vaccine Design at Every Level
- When developing a vaccine, you would normally pick a part of the organism that is not intrinsically harmful; they picked the most dangerous portion.
- Next, you would pick a part of the organism that is genetically most stable. Well, they picked the bit that apparently mutates most quickly.
- You must also try and pick a part of the organism that's most different from you so that when you elicit an immune response, it won't overlap and hit you. However, the spike protein was the least dissimilar option they had.
Dr. Mike Yeadon: (http://t.me/robinmg) "Well, so what do you make of all four companies doing the same thing [and picking the suboptimal choice]? There's a long delay, and they [peers in the industry] said, 'They must have designed to do it together.' So I think collusion and malfeasance is evident there."